In the original article there was a mistake in the author affiliation for Haoqing Zhai which was erroneously presented as “Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.”, it should instead be “Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
striatin-interacting protein 2, prognosis biomarkers, tumor immune infiltration, lung adenocarcinoma, cell proliferation
Citation
Wang J, Yuan Y, Tang L, Zhai H, Zhang D, Duan L, Jiang X and Li C (2022) Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma. Front. Oncol. 12:1109637. doi: 10.3389/fonc.2022.1109637
Received
28 November 2022
Accepted
02 December 2022
Published
13 December 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Wang, Yuan, Tang, Zhai, Zhang, Duan, Jiang and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chen Li, chen.li.scholar@gmail.com; Xiulin Jiang, jiangxiulin@mail.kiz.ac.cn; Lincan Duan, duanmumuhuosan@163.com
†These authors have contributed equally to this work
This article was submitted to Thoracic Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.